… , and management of oral mucositis associated with conventional cytotoxic therapies for …
emerging information on oral mucosal injury associated with targeted therapies. Considerations …

… International Society for Oral Oncology (MASSC/ISOO) formed the Mucositis Study Section.
… on anticancer-induced oral mucositis, detailing the physiopathology and the treatment of this …

… , and academics to study and enable drugs, biologicals, and devices to treat patients for a
variety of indications, including oral mucositis, and their employees are prohibited from having …

… In conclusion, mucositis is a common adverse effect of anticancer therapy and can contribute
negatively to patient outcomes. The optimal management of these patients is an ongoing …

… of cancer treatment, leading to dose reductions and delays in treatment. … targeted anticancer
therapies available on the market has increased the number of patients who experience oral …

… with lower rates of mucositis-related treatment delays or … Oral mucositis due to targeted
therapies for renal cell … ) is generally less severe than mucositis caused by conventional …

… Mucositis is an acute event that mostly self-resolves as the anticancer treatment ends. At
this stage the healing process is activated, during which stimuli from the submucosa …

… receive radiation therapy and experience severe oral mucositis than … In summary, cancer
therapy-related oral mucositis is … oral mucositis with subsequent courses of anticancer therapy…

… effectiveness of anticancer therapy. Tissue damage leading to oral mucositis can occur via
… of local damage to the oral epithelium by the anticancer agent. Direct stomatotoxicity usually …

… War I, injury to the mucosal surfaces of the mouth (Oral Mucositis or OM) has been a prominent
toxicity of anti-tumor therapies. With the advent of chemotherapy in 1940 the etiology of …